Diabetic retinopathy may predict the renal outcomes of patients with diabetic nephropathy

References

• Zimmet PZ, Magliano DJ, Herman WH, et al. Diabetes: a 21st century challenge. Lancet Diabetes Endocrinol. 2014;2:56–64.
   PubMed Web of Science ®Google Scholar
• International Diabetes Federation [Internet]. IDF Diabetes Atlas. 7th ed. Brussels, Belgium: International Diabetes Federation; 2015 [cited 2017 Nov 11]. Available from: http://www.diabetesatlas.org
   Google Scholar
• Guariguata L, Whiting DR, Hambleton I, et al. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014;103:137–149.
   PubMed Web of Science ®Google Scholar
• Parving HH. Diabetic nephropathy: prevention and treatment. Kidney Int. 2001;60:2041–2055.
   PubMed Web of Science ®Google Scholar
• Schena FP, Gesualdo L. Pathogenetic mechanisms of diabetic nephropathy. J Am Soc Nephrol. 2005;16 (Suppl 1):S30–S33.
   PubMed Web of Science ®Google Scholar
• Valk EJ, Bruijn JA, Bajema IM. Diabetic nephropathy in humans: pathologic diversity. Curr Opin Nephrol Hypertens. 2011;20:285–289.
   PubMed Web of Science ®Google Scholar
• Liu ZH. Nephrology in China. Nat Rev Nephrol. 2013;9:523–528.
   PubMed Web of Science ®Google Scholar
• Kute VB, Godara SM, Shah PR, et al. Outcome of deceased donor renal transplantation in diabetic nephropathy: a single-center experience from a developing country. Int Urol Nephrol. 2012;44:269–274.
   PubMed Web of Science ®Google Scholar
• Kute VB, Vanikar AV, Trivedi HL, et al. Outcome of renal transplantation in patients with diabetic nephropathy – a single-center experience. Int Urol Nephrol. 2011;43:535–541.
   PubMed Web of Science ®Google Scholar
• Zhang L, Long J, Jiang W, et al. Trends in chronic kidney disease in China. N Engl J Med. 2016;375:905–906.
   PubMed Web of Science ®Google Scholar
• Oh SW, Kim S, Na KY, et al. Clinical implications of pathologic diagnosis and classification for diabetic nephropathy. Diabetes Res Clin Pract. 2012;97:418–424.
   PubMed Web of Science ®Google Scholar
• Li L, Zhang X, Li Z, et al. Renal pathological implications in type 2 diabetes mellitus patients with renal involvement. J Diabetes Complications. 2017;31:114–121.
   PubMed Web of Science ®Google Scholar
• Fiorentino M, Bolignano D, Tesar V, et al. Renal biopsy in patients with diabetes: a pooled meta-analysis of 48 studies. Nephrol Dial Transplant. 2017;32:97–110.
   PubMed Web of Science ®Google Scholar
• Zheng Y, He M, Congdon N. The worldwide epidemic of diabetic retinopathy. Indian J Ophthalmol. 2012;60:428–431.
   PubMed Web of Science ®Google Scholar
• Gangwani RA, Lian JX, McGhee SM, et al. Diabetic retinopathy screening: global and local perspective. Hong Kong Med J. 2016;22:486–495.
   PubMed Web of Science ®Google Scholar
• Edwards MS, Wilson DB, Craven TE, et al. Associations between retinal microvascular abnormalities and declining renal function in the elderly population: the Cardiovascular Health Study. Am J Kidney Dis. 2005;46:214–224.
   PubMed Web of Science ®Google Scholar
• Jeng CJ, Hsieh YT, Yang CM, et al. Diabetic retinopathy in patients with diabetic nephropathy: development and progression. PLoS One. 2016;11:e0161897.
   PubMed Web of Science ®Google Scholar
• Park YH, Shin JA, Han JH, et al. The association between chronic kidney disease and diabetic retinopathy: the Korea National Health and Nutrition Examination Survey 2008-2010. PLoS One. 2015; 10:e0125338.
   PubMed Web of Science ®Google Scholar
• Pedro RA, Ramon SA, Marc BB, et al. Prevalence and relationship between diabetic retinopathy and nephropathy, and its risk factors in the North-East of Spain, a population-based study. Ophthal Epidemiol. 2010;17:251–265.
   PubMed Web of Science ®Google Scholar
• Wong TY, Coresh J, Klein R, et al. Retinal microvascular abnormalities and renal dysfunction: the atherosclerosis risk in communities study. J Am Soc Nephrol. 2004;15:2469–2476.
   PubMed Web of Science ®Google Scholar
• Pinsker JE, Shank T, Dassau E, et al. Comment on American Diabetes Association. Approaches to glycemic treatment. Sec. 7. In standards of medical care in diabetes-2015. Diabetes Care. 2015;38(Suppl. 1): S41–S48. Diabetes Care. 2015;38:e174.
   PubMedGoogle Scholar
• An Y, Xu F, Le W, et al. Renal histologic changes and the outcome in patients with diabetic nephropathy. Nephrol Dial Transplant. 2015;30:257–266.
   PubMed Web of Science ®Google Scholar
• Tervaert TW, Mooyaart AL, Amann K, et al. Pathologic classification of diabetic nephropathy. J Am Soc Nephrol. 2010;21:556–563.
   PubMed Web of Science ®Google Scholar
• Klein R, Zinman B, Gardiner R, et al. The relationship of diabetic retinopathy to preclinical diabetic glomerulopathy lesions in type 1 diabetic patients: the Renin-Angiotensin System Study. Diabetes. 2005;54:527–533.
   PubMed Web of Science ®Google Scholar
• Kofoed-Enevoldsen A, Jensen T, Borch-Johnsen K, et al. Incidence of retinopathy in type I (insulin-dependent) diabetes: association with clinical nephropathy. J Diabetes Complications. 1987;1:96–99.
   Google Scholar
• Schwartz MM, Lewis EJ, Leonard-Martin T, et al. Renal pathology patterns in type II diabetes mellitus: relationship with retinopathy. Nephrol Dial Transplant. 1998;13:2547–2552.
   PubMed Web of Science ®Google Scholar
• Olsen S, Mogensen CE. How often is NIDDM complicated with non-diabetic renal disease? An analysis of renal biopsies and the literature. Diabetologia. 1996;39:1638–1645.
   PubMed Web of Science ®Google Scholar
• Hong D, Zheng T, Jia-qing S, et al. Nodular glomerular lesion: a later stage of diabetic nephropathy? Diabetes Res Clin Pract. 2007;78:189–195.
   PubMed Web of Science ®Google Scholar
• Mason RM, Wahab NA. Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol. 2003;14:1358–1373.
   PubMed Web of Science ®Google Scholar
• Qian Y, Feldman E, Pennathur S, et al. From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy. Diabetes. 2008;57:1439–1445.
   PubMed Web of Science ®Google Scholar
• Yang JK, Wang YY, Liu C, et al. Urine proteome specific for eye damage can predict kidney damage in patients with type 2 diabetes: a case-control and a 5.3-year prospective cohort study. Diabetes Care. 2017;40:253–260.
   PubMed Web of Science ®Google Scholar
• Amiri AA, Hashemi-Soteh MB, Haghshenas MR, et al. Haptoglobin polymorphism in individuals with type 2 diabetic microangiopathy. North Am J Med Sci. 2013;5:529–535.
   PubMedGoogle Scholar
• Ragab SM, Safan MA, Badr EA, et al. Haptoglobin genotypes polymorphism as a risk factor for subclinical atherosclerosis in beta-thalassemia major children; a single center Egyptian study. Hematology. 2015;20:477–486.
   PubMed Web of Science ®Google Scholar
• Mima A. Inflammation and oxidative stress in diabetic nephropathy: new insights on its inhibition as new therapeutic targets. J Diabetes Res. 2013;2013:248563.
   PubMed Web of Science ®Google Scholar
• Nishimura S, Manabe I, Nagasaki M, et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med. 2009;15:914–920.
   PubMed Web of Science ®Google Scholar
• Qiu Y-y, Tang L-q. Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy. Pharmacol Res. 2016;114:251–264.
   PubMed Web of Science ®Google Scholar
• Pavkov MEWE, Fufaa GD, et al. Tumor necrosis factor receptors 1 and 2 are associated with early glomerular lesions in type 2 diabetes. Kidney Int. 2016;89:226–234. Kidney Int. 2016;90:709.
   PubMed Web of Science ®Google Scholar
• Fernandez-Juarez G, Villacorta Perez J, Luno Fernandez JL, et al. High levels of circulating TNFR1 increase the risk of all-cause mortality and progression of renal disease in type 2 diabetic nephropathy. Nephrology (Carlton). 2017;22:354–360.
   PubMed Web of Science ®Google Scholar
• Caldwell RB, Bartoli M, Behzadian MA, et al. Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress. Curr Drug Targets. 2005;6:511–524.
   PubMed Web of Science ®Google Scholar
• Sheetz MJ, King GL. Molecular understanding of hyperglycemia’s adverse effects for diabetic complications. JAMA. 2002;288:2579–2588.
   PubMed Web of Science ®Google Scholar
• Fearn A, Sheerin NS. Complement activation in progressive renal disease. World J Nephrol. 2015;4:31–40.
   PubMedGoogle Scholar
• Keir LS, Firth R, Aponik L, et al. VEGF regulates local inhibitory complement proteins in the eye and kidney. J Clin Investig. 2017;127:199–214.
   PubMed Web of Science ®Google Scholar
• Mooyaart AL, Valk EJ, van Es LA, et al. Genetic associations in diabetic nephropathy: a meta-analysis. Diabetologia. 2011;54:544–553.
   PubMed Web of Science ®Google Scholar
• McKnight AJ, Duffy S, Maxwell AP. Genetics of diabetic nephropathy: a long road of discovery. Curr Diab Rep. 2015;15:41.
   PubMed Web of Science ®Google Scholar
• Priscakova P, Minarik G, Repiska V. Candidate gene studies of diabetic retinopathy in human. Mol Biol Rep. 2016;43:1327–1345.
   PubMed Web of Science ®Google Scholar